UBS Group’s PolyPid PYPD Stock Holding History
Bought
Maintained
Sold
Other funds holding PYPD
ACM
RA
DCM
JGC
ACM
SPM
LK
XT
UBS Group's PYPD Position: Q1 2026 in Review
UBS Group sold out of PolyPid (PYPD) in Q1 2026, closing a stake of 1,499 shares — an estimated $6.51K sold.
UBS Group first reported a position in PYPD in Q3 2020 and held it in 18 quarters. The position peaked at $1.59M in Q3 2021. 19 funds tracked by Wall St. Rank hold PYPD as of Q1 2026.
- UBS Group reported no remaining PolyPid position as of Q1 2026 after selling out during the quarter.
- UBS Group sold 1,499 PolyPid shares in Q1 2026, an estimated $6.51K.
- UBS Group first reported a position in PolyPid in Q3 2020 and held it in 18 quarters.
- UBS Group's PolyPid position peaked at $1.59M in Q3 2021.
- 19 funds tracked by Wall St. Rank held PolyPid as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.